Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals
Gian Luca Salvagno, Brandon Michael Henry, Laura Pighi, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 6, pp. 930-933
Open Access | Times Cited: 17

Showing 17 citing articles:

The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
Clinical Immunology (2023) Vol. 255, pp. 109762-109762
Open Access | Times Cited: 19
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers
Andrea Padoan, Chiara Cosma, Foscarina Della Rocca, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 7, pp. 1110-1115
Open Access | Times Cited: 17
Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection
Maria Teresa Vietri, Giovanna D’Elia, Gemma Caliendo, et al.
Vaccine (2022) Vol. 40, Iss. 39, pp. 5726-5731
Open Access | Times Cited: 17
The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses
Konstantin Föhse, Büsra Geckin, Martijn Zoodsma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers
Ioannis Sarrigeorgiou, Dimitra Moschandreou, Alexios Dimitriadis, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0277827-e0277827
Open Access | Times Cited: 13
Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2
Julien Favresse, Jonathan Douxfils, Brandon Michael Henry, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 61, Iss. 5, pp. 811-821
Open Access | Times Cited: 9
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility
Alessia Lai, Barbara Caimi, Marco Franzetti, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 446-446
Open Access | Times Cited: 8
Stability and Numerical Simulations of a New SVIR Model with Two Delays on COVID-19 Booster Vaccination
Xinyu Liu, Yuting Ding
Mathematics (2022) Vol. 10, Iss. 10, pp. 1772-1772
Open Access | Times Cited: 8
Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers
Laura Valentina Renna, Fabio Bertani, Alessandro Podio, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 463-463
Open Access | Times Cited: 4
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
Chiara Agrati, Concetta Castilletti, Simone Battella, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
Sergio A. Rodriguez‐Aponte, Neil C. Dalvie, Ting Y. Wong, et al.
Vaccine (2022) Vol. 41, Iss. 5, pp. 1108-1118
Open Access | Times Cited: 6
Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine
Imad Asmar, Omar Almahmoud, Khalid Yaseen, et al.
Clinical Epidemiology and Global Health (2023) Vol. 22, pp. 101330-101330
Open Access | Times Cited: 2
The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration
Jakub Swadźba, Tomasz Anyszek, Andrzej Panek, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 278-278
Open Access | Times Cited: 1
Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds
Andrea Padoan, Chiara Cosma, Luisa Galla, et al.
Clinica Chimica Acta (2022) Vol. 529, pp. 104-108
Open Access | Times Cited: 1
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers
Gian Luca Salvagno, Brandon Michael Henry, Laura Pighi, et al.
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio (2022) Vol. 3, Iss. 2, pp. 167-170
Open Access
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top